# HAEGARDA C1 Esterase Inhibitor Subcutaneous (Human)

NDC: 63833-828
Generic name: HUMAN C1-ESTERASE INHIBITOR
Labeler / Manufacturer: CSL Behring GmbH
Product type: PLASMA DERIVATIVE
Marketing category: Biologic License Application
Dosage form: KIT
Routes: —
Marketing started: 20170622

FDA application: BLA125606

## Active ingredients

—

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63833-828"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63833-828